Steward Partners Investment Advisory, LLC Biogen Inc. Transaction History

Steward Partners Investment Advisory, LLC

$10.6 Billion
Q3 2024

A detailed history of Steward Partners Investment Advisory, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Steward Partners Investment Advisory, LLC holds 2,172 shares of BIIB stock, worth $323,671. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,172

Previous 1,742 24.68%

Holding current value

$323,671

Previous $403,000 4.47%

% of portfolio

0.0%

Previous 0.0%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$189.07 - $236.8 $81,300 - $101,824	430 Added 24.68%	2,172 $421,000
Q2 2024 Aug 08, 2024	SELL	$190.52 - $236.72 $24,577 - $30,536	-129 Reduced 6.89%	1,742 $403,000
Q1 2024 May 15, 2024	BUY	$212.02 - $267.71 $15,053 - $19,007	71 Added 3.94%	1,871 $403,000
Q4 2023 Feb 12, 2024	SELL	$222.59 - $267.94 $2.09 Million - $2.52 Million	-9,400 Reduced 83.93%	1,800 $465,000
Q3 2023 Nov 13, 2023	BUY	$253.3 - $285.89 $2.38 Million - $2.68 Million	9,389 Added 518.44%	11,200 $2.88 Million
Q2 2023 Aug 14, 2023	SELL	$275.25 - $318.06 $10,184 - $11,768	-37 Reduced 2.0%	1,811 $515,000
Q1 2023 May 15, 2023	SELL	$256.56 - $292.34 $40,279 - $45,897	-157 Reduced 7.83%	1,848 $513,000
Q4 2022 Feb 15, 2023	BUY	$252.44 - $306.72 $15,903 - $19,323	63 Added 3.24%	2,005 $555,000
Q3 2022 Nov 10, 2022	BUY	$194.69 - $268.46 $2,725 - $3,758	14 Added 0.73%	1,942 $519,000
Q2 2022 Aug 04, 2022	SELL	$187.54 - $223.02 $1,312 - $1,561	-7 Reduced 0.36%	1,928 $393,000
Q1 2022 May 02, 2022	SELL	$193.77 - $244.14 $32,165 - $40,527	-166 Reduced 7.9%	1,935 $408,000
Q4 2021 Feb 08, 2022	BUY	$223.92 - $287.77 $38,738 - $49,784	173 Added 8.97%	2,101 $504,000
Q3 2021 Nov 12, 2021	SELL	$282.99 - $369.05 $34,807 - $45,393	-123 Reduced 6.0%	1,928 $546,000
Q2 2021 Aug 13, 2021	SELL	$259.0 - $414.71 $185,962 - $297,761	-718 Reduced 25.93%	2,051 $710,000
Q1 2021 May 14, 2021	BUY	$242.95 - $284.63 $113,943 - $133,491	469 Added 20.39%	2,769 $774,000
Q4 2020 Feb 11, 2021	SELL	$236.26 - $355.63 $19,609 - $29,517	-83 Reduced 3.48%	2,300 $563,000
Q3 2020 Oct 30, 2020	BUY	$264.77 - $305.71 $104,319 - $120,449	394 Added 19.81%	2,383 $676,000
Q2 2020 Aug 06, 2020	BUY	$258.66 - $342.55 $102,946 - $136,334	398 Added 25.02%	1,989 $532,000
Q1 2020 Apr 29, 2020	SELL	$268.85 - $341.04 $182,549 - $231,566	-679 Reduced 29.91%	1,591 $503,000
Q4 2019 Jan 17, 2020	SELL	$220.06 - $304.07 $33,229 - $45,914	-151 Reduced 6.24%	2,270 $673,000
Q3 2019 Oct 30, 2019	BUY	$217.44 - $243.88 $65,449 - $73,407	301 Added 14.2%	2,421 $563,000
Q2 2019 Jul 25, 2019	SELL	$219.29 - $241.72 $162,493 - $179,114	-741 Reduced 25.9%	2,120 $495,000
Q1 2019 Apr 30, 2019	SELL	$216.71 - $338.96 $200,240 - $313,199	-924 Reduced 24.41%	2,861 $676,000
Q4 2018 Jan 15, 2019	SELL	$278.5 - $352.75 $40,104 - $50,796	-144 Reduced 3.67%	3,785 $1.14 Million
Q3 2018 Oct 23, 2018	SELL	$293.51 - $383.83 $242,439 - $317,043	-826 Reduced 17.37%	3,929 $1.39 Million
Q2 2018 Jul 20, 2018	BUY	$257.52 - $306.91 $13,391 - $15,959	52 Added 1.11%	4,755 $1.38 Million
Q1 2018 Apr 20, 2018	BUY	$260.13 - $367.91 $140,990 - $199,407	542 Added 13.03%	4,703 $1.29 Million
Q4 2017 Jan 19, 2018	BUY	$307.64 - $344.58 $501,145 - $561,320	1,629 Added 64.34%	4,161 $1.33 Million
Q3 2017 Nov 22, 2017	BUY	$281.15 - $329.69 $292,677 - $343,207	1,041 Added 69.82%	2,532 $792,000
Q2 2017 Nov 22, 2017	BUY	N/A	489 Added 48.8%	1,491 $404,000
Q1 2017 Nov 22, 2017	BUY	N/A	552 Added 122.67%	1,002 $273,000
Q4 2016 Nov 22, 2017	BUY	N/A	450	450 $127,000

Others Institutions Holding BIIB

# of Institutions

1,037

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.5B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Steward Partners Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Steward Partners Investment Advisory, LLC with notifications on news.

Account

Steward Partners Investment Advisory, LLC Biogen Inc. Transaction History